Pediatric Interventional Cardiology Market – Global Industry Analysis and Forecast (2022-2029)


Pediatric Interventional Cardiology Market was valued at US$ 1.79 Bn in 2022 and is expected to reach US$ 3.20 Bn by 2029, at a CAGR of 8.66% during a forecast period.

The report includes the analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.Global Pediatric Interventional Cardiology Market To know about the Research Methodology :- Request Free Sample Report

Pediatric Interventional Cardiology Market Dynamics

Paediatrics is a branch of medicine that includes the medical care of infants, children, and adolescents. The constant progress of novel minimally invasive devices and the growing population of pediatric patients are boosting the growth of the market during the forecast period. The rising occurrences of congenital heart conditions among paediatric patients, initiatives taken by regulatory authorities to reinforce the interventional cardiology segment, and rising expenses by market applicants for the R&D of novel heart controller products are also propelling the growth of the global paediatric interventional cardiology market.

Pediatric Interventional Cardiology Market Segment Analysis

The complex regulatory procedures are limiting the growth of the market. Closure devices are used to close a fault between the right and left sides of the heart. Some of these birth defects are located between the upper chambers that are atria of the heart.

Transcatheter aortic valve replacement (TAVR) is an invasive procedure to exchange a narrowed aortic valve that fails to open aortic valve stenosis properly. In the TAVR procedure, doctors insert a catheter in a patient’s leg or chest directed towards the heart. Transcatheter aortic valve replacement has some risk factors, which may include bleeding, blood vessel complications, stroke, kidney disease, and heart attack. TAVR improves the lives of people with aortic stenosis whose surgery is too risky and can reduce the risk of death.

Pediatric Interventional Cardiology Market Regional Insights

Europe is estimated for the largest share of the pediatric interventional cardiology market owing to numerous approved interventional cardiology devices present in the European market as well as funds by venture capitalists, and collaborations among the key players in the market. The Asia-Pacific region has significant growth opportunities owing to the high growth in the improving healthcare infrastructure in the region. Moreover, the progress in government investments for improving pediatric care facilities is driving the growth of the region.

The report covers a comprehensive study of major market drivers, restraints, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.

Paediatric Interventional Cardiology Market, Key Highlights:

• Global Paediatric Interventional Cardiology Market analysis and forecast, in terms of value.
• Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Paediatric Interventional Cardiology Market
• Global Paediatric Interventional Cardiology Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.
• Global Paediatric Interventional Cardiology Market strategic analysis with respect to individual growth trends, future prospects along the contribution of various sub-market stakeholders have been considered under the scope of the study.
• Global Paediatric Interventional Cardiology Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.
• Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.
• Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Paediatric Interventional Cardiology Market are also profiled.

Global Pediatric Interventional Cardiology Market Scope: Inquire before buying






Global Pediatric Interventional Cardiology Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2017 to 2022
Market Size in 2022:
US $ 1.79 Bn.




Forecast Period 2023 to 2029 CAGR:
8.66%
Market Size in 2029:
US $ 3.20 Bn.




 Segments Covered:
by Device Type
• Congenital Heart Defect Closure Devices
• Transcatheter Heart Valves
• Other Device Type




by End Users
• Hospitals
• Laboratories
• Home Healthcare
• Other End Users




by Region
• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)






Pediatric Interventional Cardiology Market, Key Players are:

• Danaher
• Abbott Laboratories
• Siemens AG
• GENERAL ELECTRIC
• Toshiba Corporation
• Boston Scientific Corporation
• W.L. Gore & Associates, Inc.
• Johnson & Johnson Services, Inc.
• BIOTRONIK
• Koninklijke Philips N.V.
• F. Hoffmann-La Roche Ltd.
• Medtronic
• NuMED, Inc.
• Cook
• PEDIAVASCULAR
• Edwards Lifesciences Corporation
• Agilent Technologies
• Pfm Medical Ag
• Scranton Gillette Communication

Frequently Asked Questions:

1. Which region has the largest share in Global Pediatric Interventional Cardiology Market?
Ans: Europe region holds the highest share in 2022.

2. What is the growth rate of Global Pediatric Interventional Cardiology Market?
Ans: The Global Pediatric Interventional Cardiology Market is growing at a CAGR of 8.66% during forecasting period 2023-2029.

3. What is scope of the Global Pediatric Interventional Cardiology market report?
Ans: Global Pediatric Interventional Cardiology Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Pediatric Interventional Cardiology market?
Ans: The important key players in the Global Pediatric Interventional Cardiology Market are – Danaher, Abbott Laboratories, Siemens AG, GENERAL ELECTRIC, Toshiba Corporation, Boston Scientific Corporation, W.L. Gore & Associates, Inc., Johnson & Johnson Services, Inc., BIOTRONIK, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Medtronic, NuMED, Inc., Cook, PEDIAVASCULAR, Edwards Lifesciences Corporation, Agilent Technologies, Pfm Medical Ag, and Scranton Gillette Communication

5. What is the study period of this market?
Ans: The Global Pediatric Interventional Cardiology Market is studied from 2022 to 2029. 





Global pediatric interventional cardiology market

1. Preface
1.1. Research Objectives
1.2. Report Scope and Market Segmentation

2. Assumptions and Research Methodology
2.1. Abbreviations

3. Executive Summary
3.1. Global Pediatric Interventional Cardiology Market Size, by Market Value (US$ Bn) and Market

4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.3. Drivers and Restraints Snapshot Analysis
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Porter’s Analysis
4.3.5. Value Chain Analysis
4.3.6. SWOT Analysis
4.3.7. Key Trends in Global Pediatric Interventional Cardiology Market

5. Global Pediatric Interventional Cardiology Market Analysis and Forecast
5.1. Global Pediatric Interventional Cardiology Market Size& Y-o-Y Growth Analysis
5.1.1. North America
5.1.2. Europe
5.1.3. Asia Pacific
5.1.4. Middle East & Africa
5.1.5. South America

6. Global Pediatric Interventional Cardiology Market Analysis and Forecast, By Device Type
6.1. Introduction and Definition
6.2. Global Pediatric Interventional Cardiology Market Value Share Analysis, By Device Type
6.3. Global Pediatric Interventional Cardiology Market Size (US$ Bn) Forecast, By Device Type
6.4. Global Pediatric Interventional Cardiology Market Analysis, By Device Type
6.5. Global Pediatric Interventional Cardiology Market Attractiveness Analysis, By Device Type
6.6. Key Trends
6.6.1. Key Developments

7. Global Pediatric Interventional Cardiology Market Analysis and Forecast, By End User
7.1. Introduction and Definition
7.2. Global Pediatric Interventional Cardiology Market Value Share Analysis, By End User
7.3. Global Pediatric Interventional Cardiology Market Size (US$ Bn) Forecast, By End User
7.4. Global Pediatric Interventional Cardiology Market Analysis, By End User
7.5. Global Pediatric Interventional Cardiology Market Attractiveness Analysis, By End User
7.6. Key Trends
7.6.1. Key Developments

8. Global Pediatric Interventional Cardiology Market Analysis, by Region
8.1. Global Pediatric Interventional Cardiology Market Value Share Analysis, by Region
8.2. Global Pediatric Interventional Cardiology Market Size (US$ Bn) Forecast, by Region
8.3. Global Pediatric Interventional Cardiology Market Attractiveness Analysis, by Region
8.4. Key Trends
8.4.1. Key Developments

9. North America Pediatric Interventional Cardiology Market Analysis
9.1. North America Pediatric Interventional Cardiology Market Overview
9.2. North America Pediatric Interventional Cardiology Market Value Share Analysis, By Device Type
9.3. North America Pediatric Interventional Cardiology Market Forecast, By Device Type
9.3.1. Congenital Heart Defect Closure Devices
9.3.2. Transcatheter Heart Valves
9.3.3. Other Device Type
9.4. North America Pediatric Interventional Cardiology Market Value Share Analysis, By End User
9.5. North America Pediatric Interventional Cardiology Market Forecast, By End User
9.5.1. Hospitals
9.5.2. Laboratories
9.5.3. Home Healthcare
9.5.4. Other End Users
9.6. North America Pediatric Interventional Cardiology Market Value Share Analysis, by Country
9.7. North America Pediatric Interventional Cardiology Market Forecast, by Country
9.7.1. U.S.
9.7.2. Canada
9.8. North America Pediatric Interventional Cardiology Market Analysis, by Country
9.9. U.S. Pediatric Interventional Cardiology Market Forecast, By Device Type
9.9.1. Congenital Heart Defect Closure Devices
9.9.2. Transcatheter Heart Valves
9.9.3. Other Device Type
9.10. U.S. Pediatric Interventional Cardiology Market Forecast, By End User
9.10.1. Hospitals
9.10.2. Laboratories
9.10.3. Home Healthcare
9.10.4. Other End Users
9.11. Canada Pediatric Interventional Cardiology Market Forecast, By Device Type
9.11.1. Congenital Heart Defect Closure Devices
9.11.2. Transcatheter Heart Valves
9.11.3. Other Device Type
9.12. Canada Pediatric Interventional Cardiology Market Forecast, By End User
9.12.1. Hospitals
9.12.2. Laboratories
9.12.3. Home Healthcare
9.12.4. Other End Users
9.13. North America Pediatric Interventional Cardiology Market Attractiveness Analysis
9.13.1. By Device Type
9.13.2. By End User
9.14. PEST Analysis
9.15. Key Trends
9.15.1. Key Developments

10. Europe Pediatric Interventional Cardiology Market Analysis
10.1. Europe Pediatric Interventional Cardiology Market Overview
10.2. Europe Pediatric Interventional Cardiology Market Value Share Analysis, By Device Type
10.3. Europe Pediatric Interventional Cardiology Market Forecast, By Device Type
10.3.1. Congenital Heart Defect Closure Devices
10.3.2. Transcatheter Heart Valves
10.3.3. Other Device Type
10.4. Europe Pediatric Interventional Cardiology Market Value Share Analysis, By End User
10.5. Europe Pediatric Interventional Cardiology Market Forecast, By End User
10.5.1. Hospitals
10.5.2. Laboratories
10.5.3. Home Healthcare
10.5.4. Other End Users
10.6. Europe Pediatric Interventional Cardiology Market Value Share Analysis, by Country
10.7. Europe Pediatric Interventional Cardiology Market Forecast, by Country
10.7.1. Germany
10.7.2. U.K.
10.7.3. France
10.7.4. Italy
10.7.5. Spain
10.7.6. Rest of Europe
10.8. Europe Pediatric Interventional Cardiology Market Analysis, by Country/ Sub-region
10.9. Germany Pediatric Interventional Cardiology Market Forecast, By Device Type
10.9.1. Congenital Heart Defect Closure Devices
10.9.2. Transcatheter Heart Valves
10.9.3. Other Device Type
10.10. Germany Pediatric Interventional Cardiology Market Forecast, By End User
10.10.1. Hospitals
10.10.2. Laboratories
10.10.3. Home Healthcare
10.10.4. Other End Users
10.11. U.K. Pediatric Interventional Cardiology Market Forecast, By Device Type
10.11.1. Congenital Heart Defect Closure Devices
10.11.2. Transcatheter Heart Valves
10.11.3. Other Device Type s
10.12. U.K. Pediatric Interventional Cardiology Market Forecast, By End User
10.12.1. Hospitals
10.12.2. Laboratories
10.12.3. Home Healthcare
10.12.4. Other End Users
10.13. France Pediatric Interventional Cardiology Market Forecast, By Device Type
10.13.1. Congenital Heart Defect Closure Devices
10.13.2. Transcatheter Heart Valves
10.13.3. Other Device Type
10.14. France Pediatric Interventional Cardiology Market Forecast, By End User
10.14.1. Hospitals
10.14.2. Laboratories
10.14.3. Home Healthcare
10.14.4. Other End Users
10.15. Italy Pediatric Interventional Cardiology Market Forecast, By Device Type
10.15.1. Congenital Heart Defect Closure Devices
10.15.2. Transcatheter Heart Valves
10.15.3. Other Device Type
10.16. Italy Pediatric Interventional Cardiology Market Forecast, By End User
10.16.1. Hospitals
10.16.2. Laboratories
10.16.3. Home Healthcare
10.16.4. Other End Users
10.17. Spain Pediatric Interventional Cardiology Market Forecast, By Device Type
10.17.1. Congenital Heart Defect Closure Devices
10.17.2. Transcatheter Heart Valves
10.17.3. Other Device Type
10.18. Spain Pediatric Interventional Cardiology Market Forecast, By End User
10.18.1. Hospitals
10.18.2. Laboratories
10.18.3. Home Healthcare
10.18.4. Other End Users
10.19. Rest of Europe Pediatric Interventional Cardiology Market Forecast, By Device Type
10.19.1. Congenital Heart Defect Closure Devices
10.19.2. Transcatheter Heart Valves
10.19.3. Other Device Type
10.20. Rest of Europe Pediatric Interventional Cardiology Market Forecast, By End User
10.20.1. Hospitals
10.20.2. Laboratories
10.20.3. Home Healthcare
10.20.4. Other End Users
10.21. Europe Pediatric Interventional Cardiology Market Attractiveness Analysis
10.21.1. By Device Type
10.21.2. By End User
10.22. PEST Analysis
10.23. Key Trends
10.23.1. Key Developments

11. Asia Pacific Pediatric Interventional Cardiology Market Analysis
11.1. Asia Pacific Pediatric Interventional Cardiology Market Overview
11.2. Asia Pacific Pediatric Interventional Cardiology Market Value Share Analysis, By Device Type
11.3. Asia Pacific Pediatric Interventional Cardiology Market Forecast, By Device Type
11.3.1. Congenital Heart Defect Closure Devices
11.3.2. Transcatheter Heart Valves
11.3.3. Other Device Type
11.4. Asia Pacific Pediatric Interventional Cardiology Market Value Share Analysis, By End User
11.5. Asia Pacific Pediatric Interventional Cardiology Market Forecast, By End User
11.5.1. Hospitals
11.5.2. Laboratories
11.5.3. Home Healthcare
11.5.4. Other End Users
11.6. Asia Pacific Pediatric Interventional Cardiology Market Value Share Analysis, by Country
11.7. Asia Pacific Pediatric Interventional Cardiology Market Forecast, by Country
11.7.1. China
11.7.2. India
11.7.3. Japan
11.7.4. ASEAN
11.7.5. Rest of Asia Pacific
11.8. Asia Pacific Pediatric Interventional Cardiology Market Analysis, by Country/ Sub-region
11.9. China Pediatric Interventional Cardiology Market Forecast, By Device Type
11.9.1. Congenital Heart Defect Closure Devices
11.9.2. Transcatheter Heart Valves
11.9.3. Other Device Type
11.10. China Pediatric Interventional Cardiology Market Forecast, By End User
11.10.1. Hospitals
11.10.2. Laboratories
11.10.3. Home Healthcare
11.10.4. Other End Users
11.11. India Pediatric Interventional Cardiology Market Forecast, By Device Type
11.11.1. Congenital Heart Defect Closure Devices
11.11.2. Transcatheter Heart Valves
11.11.3. Other Device Type
11.12. India Pediatric Interventional Cardiology Market Forecast, By End User
11.12.1. Hospitals
11.12.2. Laboratories
11.12.3. Home Healthcare
11.12.4. Other End Users
11.13. Japan Pediatric Interventional Cardiology Market Forecast, By Device Type
11.13.1. Congenital Heart Defect Closure Devices
11.13.2. Transcatheter Heart Valves
11.13.3. Other Device Type
11.14. Japan Pediatric Interventional Cardiology Market Forecast, By End User
11.14.1. Hospitals
11.14.2. Laboratories
11.14.3. Home Healthcare
11.14.4. Other End Users
11.15. ASEAN Pediatric Interventional Cardiology Market Forecast, By Device Type
11.15.1. Congenital Heart Defect Closure Devices
11.15.2. Transcatheter Heart Valves
11.15.3. Other Device Type
11.16. ASEAN Pediatric Interventional Cardiology Market Forecast, By End User
11.16.1. Hospitals
11.16.2. Laboratories
11.16.3. Home Healthcare
11.16.4. Other End Users
11.17. Rest of Asia Pacific Pediatric Interventional Cardiology Market Forecast, By Device Type
11.17.1. Congenital Heart Defect Closure Devices
11.17.2. Transcatheter Heart Valves
11.17.3. Other Device Type
11.18. Rest of Asia Pacific Pediatric Interventional Cardiology Market Forecast, By End User
11.18.1. Hospitals
11.18.2. Laboratories
11.18.3. Home Healthcare
11.18.4. Other End Users
11.19. Asia Pacific Pediatric Interventional Cardiology Market Attractiveness Analysis
11.19.1. By Device Type
11.19.2. By End User
11.20. PEST Analysis
11.21. Key Trends
11.21.1. Key Developments

12. Middle East & Africa Pediatric Interventional Cardiology Market Analysis
12.1. Middle East & Africa Pediatric Interventional Cardiology Market Overview
12.2. Middle East & Africa Pediatric Interventional Cardiology Market Value Share Analysis, By Device Type
12.3. Middle East & Africa Pediatric Interventional Cardiology Market Forecast, By Device Type
12.3.1. Congenital Heart Defect Closure Devices
12.3.2. Transcatheter Heart Valves
12.3.3. Other Device Type
12.4. Middle East & Africa Pediatric Interventional Cardiology Market Value Share Analysis, By End User
12.5. Middle East & Africa Pediatric Interventional Cardiology Market Forecast, By End User
12.5.1. Hospitals
12.5.2. Laboratories
12.5.3. Home Healthcare
12.5.4. Other End Users
12.6. Middle East & Africa Pediatric Interventional Cardiology Market Forecast, by Country
12.6.1. GCC
12.6.2. South Africa
12.6.3. Rest of Middle East & Africa
12.7. Middle East & Africa Pediatric Interventional Cardiology Market Analysis, by Country/ Sub-region
12.8. GCC Pediatric Interventional Cardiology Market Forecast, By Device Type
12.8.1. Congenital Heart Defect Closure Devices
12.8.2. Transcatheter Heart Valves
12.8.3. Other Device Type
12.9. GCC Pediatric Interventional Cardiology Market Forecast, By End User
12.9.1. Hospitals
12.9.2. Laboratories
12.9.3. Home Healthcare
12.9.4. Other End Users
12.10. Others South Africa Pediatric Interventional Cardiology Market Forecast, By Device Type
12.10.1. Congenital Heart Defect Closure Devices
12.10.2. Transcatheter Heart Valves
12.10.3. Other Device Type
12.11. South Africa Pediatric Interventional Cardiology Market Forecast, By End User
12.11.1. Hospitals
12.11.2. Laboratories
12.11.3. Home Healthcare
12.11.4. Other End Users
12.12. Rest of Middle East & Africa Pediatric Interventional Cardiology Market Forecast, By Device Type
12.12.1. Congenital Heart Defect Closure Devices
12.12.2. Transcatheter Heart Valves
12.12.3. Other Device Type
12.13. Rest of Middle East & Africa Pediatric Interventional Cardiology Market Forecast, By End User
12.13.1. Hospitals
12.13.2. Laboratories
12.13.3. Home Healthcare
12.13.4. Other End Users
12.14. Middle East & Africa Pediatric Interventional Cardiology Market Attractiveness Analysis
12.14.1. By Device Type
12.14.2. By End User
12.15. PEST Analysis
12.16. Key Trends
12.16.1. Key Developments

13. South America Pediatric Interventional Cardiology Market Analysis
13.1. South America Pediatric Interventional Cardiology Market Overview
13.2. South America Pediatric Interventional Cardiology Market Value Share Analysis, By Device Type
13.3. South America Pediatric Interventional Cardiology Market Forecast, By Device Type
13.3.1. Congenital Heart Defect Closure Devices
13.3.2. Transcatheter Heart Valves
13.3.3. Other Device Type
13.4. South America Pediatric Interventional Cardiology Market Value Share Analysis, By End User
13.5. South America Pediatric Interventional Cardiology Market Forecast, By End User
13.5.1. Hospitals
13.5.2. Laboratories
13.5.3. Home Healthcare
13.5.4. Other End Users
13.6. South America Pediatric Interventional Cardiology Market Value Share Analysis, by Country
13.7. South America Pediatric Interventional Cardiology Market Forecast, by Country
13.7.1. Brazil
13.7.2. Mexico
13.7.3. Rest of South America
13.8. South America Pediatric Interventional Cardiology Market Analysis, by Country/ Sub-region
13.9. Brazil Pediatric Interventional Cardiology Market Forecast, By Device Type
13.9.1. Congenital Heart Defect Closure Devices
13.9.2. Transcatheter Heart Valves
13.9.3. Other Device Type
13.10. Brazil Pediatric Interventional Cardiology Market Forecast, By End User
13.10.1. Hospitals
13.10.2. Laboratories
13.10.3. Home Healthcare
13.10.4. Other End Users
13.11. Mexico Pediatric Interventional Cardiology Market Forecast, By Device Type
13.11.1. Congenital Heart Defect Closure Devices
13.11.2. Transcatheter Heart Valves
13.11.3. Other Device Type
13.12. Mexico Pediatric Interventional Cardiology Market Forecast, By End User
13.12.1. Hospitals
13.12.2. Laboratories
13.12.3. Home Healthcare
13.12.4. Other End Users
13.13. Rest of South America Pediatric Interventional Cardiology Market Forecast, By Device Type
13.13.1. Congenital Heart Defect Closure Devices
13.13.2. Transcatheter Heart Valves
13.13.3. Other Device Type
13.14. Rest of South America Pediatric Interventional Cardiology Market Forecast, By End User
13.14.1. Hospitals
13.14.2. Laboratories
13.14.3. Home Healthcare
13.14.4. Other End Users
13.15. South America Pediatric Interventional Cardiology Market Attractiveness Analysis
13.15.1. By Device Type
13.15.2. By End User
13.16. PEST Analysis
13.17. Key Trends
13.17.1. Key Developments

14. Company Landscape
14.1. Market Share Analysis, by Company
14.2. Competition Matrix
14.3. Competitive Benchmarking of Company and Services
14.4. Company Profiles: Key Players
14.4.1. Scranton Gillette Communication.
14.4.1.1. Company Overview
14.4.1.2. Financial Overview
14.4.1.3. Business Strategy
14.4.1.4. Recent Developments
14.4.1.5. Development Footprint
14.4.2. Danaher
14.4.3. Abbott Laboratories
14.4.4. Siemens AG
14.4.5. GENERAL ELECTRIC
14.4.6. Toshiba Corporation
14.4.7. Boston Scientific Corporation
14.4.8. W.L. Gore & Associates, Inc.
14.4.9. Johnson & Johnson Services, Inc.
14.4.10. BIOTRONIK
14.4.11. Koninklijke Philips N.V.
14.4.12. F. Hoffmann-La Roche Ltd.
14.4.13. Medtronic
14.4.14. NuMED, Inc.
14.4.15. Cook
14.4.16. PEDIAVASCULAR
14.4.17. Edwards Lifesciences Corporation
14.4.18. Agilent Technologies
14.4.19. Pfm Medical Ag

15. Primary Key Insights
  • INQUIRE BEFORE BUYING